| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | C98V9UMX3D |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | IgG receptor FcRn large subunit p51 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Graves Ophthalmopathy | 3 | D049970 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 2 | D000744 | ClinicalTrials |
| Graves Disease | 2 | D006111 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | D020277 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650514 |
| FDA SRS | C98V9UMX3D |
CONTENTS